State Street Corp Pulse Biosciences, Inc. Call Options Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLSE
# of Institutions
66Shares Held
4.8MCall Options Held
138KPut Options Held
96.2K-
Black Rock Inc. New York, NY1.15MShares$17.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA905KShares$14.2 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC783KShares$12.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA424KShares$6.64 Million0.0% of portfolio
-
Griffin Asset Management, Inc.257KShares$4.03 Million0.51% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $581M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...